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ABSTRACT
Ficus thonningii extract is known for its
ethnobotanical uses in treatment of various
infections, including those of the urinogenital
tract. This study investigated the antimicrobial
activity of extracts of F. thonningii on thirty four
bacterial isolates from symptomatic urinary
tract infections and four Candida isolates from
vagina. Qualitative phytochemical screening
and successive gradient extraction of dried,
pulverized leaves was carried out with hexane,
ethyl acetate and methanol. Bioactivity-guided
fractionation of the ethyl acetate extract was
done using vacuum liquid chromatography.
Antibiotic susceptibility testing of bacterial
isolates was determined using standard
antibiotic discs. Antimicrobial activity of the
crude extracts and fractions was carried out on
isolates using the agar well diffusion method.
Minimum inhibitory concentrations (MIC) and
minimum biocidal concentrations (MBC) were
determined by agar-dilution and broth dilution
respectively. Bactericidal kinetics of the ethyl
acetate extracts of both plants was conducted
using
the
viable
count
technique.
Phytochemicals present include terpenoids,
saponins, tannins and flavonoids. The majority
of clinical isolates were multi-drug resistant.
The extracts and fractions of F. thonningii
showed broad spectrum antimicrobial activity
on susceptible as well as multi-antibiotic
resistant isolates. The MIC ranged from 6.25
mg/mL to 12.5 mg/mL while MBC was between

6.25 mg/mL and > 50mg/mL. The ethyl acetate
extract showed potent bactericidal activity in a
concentration-dependent manner on the
microorganisms, with 100% microbicidal
activity at 25 mg/mL within six hours for
Staphyloccocus aureus and three hours for
Candida albicans. Leaf extracts of F. thonningii
possess potent antimicrobial activity and may be
useful in developing chemotherapeutic agents
for the treatment of microbial infections.
INTRODUCTION
Plants and plant products, exemplified by
ancient Chinese, African and Indian herbs, have
been used in the treatment and management of
infectious diseases since antiquity.
The
effectiveness of plants in the treatment of infections
can be inferred from the number of drugs derived
from them (Gupta et al., 2012). Although standard
antibiotics are useful in treatment of infectious
diseases, the continuing emergence of resistant
organisms, undesired effects and exorbitant cost of
drugs pose a significant challenge (Neuhauser et al.,
2003; Saga and Yamaguchi, 2009; Willey et al.,
2008). Hence there is continued search for
molecules with antimicrobial activity.
Ficus thonningii (Blume) is a tree in the
Moraceae family (Orwa et al., 2009). F. thonningii
is commonly referred to as common wild fig while
the Yoruba tribe of Nigeria refers to it as ‘odan’
(Orwa et al., 2009), and used ethnobotanically in
the treatment of urinary tract infections, veneral
diseases, diarrhoea, dermatophyte infections
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Test for saponins. Saponins were detected using
the froth test in which 0.5 g of sample was weighed
into a test tube containing 5 ml of distilled water.
This was shaken and fitered. The filterate was
shaken vigorously for a few minutes and observed
for persistent frothing which is indicative of a
positive result. To further confirm the presence of
saponins, three drops of olive oil was added to tubes
with persistent froth. The formation of emulsion
confirms the presence of saponins.

amongst others (Dangarembizi et al., 2013;
Egharevba et al., 2015; Muthu et al., 2006;
Nwachukwu et al., 2010; Orwa et al., 2009;
Shanavaskhan et al., 2012; Teklehaymanot and
Giday, 2007). F. thonningii has been shown to be
non-toxic to mammals at high doses in a number of
in-vivo studies (Aniagu et al., 2008; Coker et al.,
2009); explaining why it has not been associated
with toxicity in ethnomedicine. Extracts of Ficus
thonningii have been shown to be active against
clinical bacteria isolated from various sources
(Koné et al., 2004; Ndukwe et al., 2007; Usman et
al., 2009) as well as fungi (Coker et al., 2016;
Oyelana et al., 2011) and protozoa (Dangarembizi
et al., 2014; Falade et al., 2014) but there is little
information on its effect on pathogens of urinary
tract and sexually transmitted infections for which
it is used in local traditional medicine. Hence, this
study investigated the antimicrobial activity of F.
thonningii extracts on pathogens isolated from
vagina and symptomatic urinary tract infections.
We hypothesized that extracts of F. thonningii is
effective against selected isolates from urinary tract
infections.

Test for terpenoids. Plant sample (0.5 g) was
weighed into a clean test tube containing 2 ml of
chloroform. This was then shaken and thereafter
filtered after which concentrated H2SO4 was added
to the filtrate. A reddish-brown color at the
interphase indicates the presence of terpenoids.
Test for alkaloids. Pulverized plant leaves (0.5
g) were acidified with a mixture of 1% hydro
chloric acid and ethanol for 2 minutes. This was
shaken after which it was filtered through a filter
paper. Ammonium hydroxide was added to the
filtrate in a clean test tube after which chloroform
was added. The chloroform layer was removed with
the aid of a Pasteur pipette and then a few drops of
Dragendorff’s reagent were added. The formation
of orange brown precipitate indicates the presence
of alkaloids.

MATERIALS AND METHODS
Plant Collection. Leaves of F. thonningii were
collected from Ojoo in Ibadan and authenticated at
Forestry Research Institute of Nigeria (FRIN),
Ibadan, Nigeria where a herbarium sample with
voucher number FHI 1106898 was deposited. The
leaves were then dried at room temperature (25 ± 3
°C) and thereafter pulverized with an industrial
grinder.

Test for cardiac glycosides. To detect cardiac
glycosides, 0.5 g of sample was weighed into a
clean test tube containing 5 ml of water. This was
then filtered and 2 ml of glacial acetic acid
containing a drop of ferric chloride was added to
the filtrate after which concentrated hydrogen tetra
oxo sulphate (VI) acid was added. A reddish-brown
color at the interphase indicates the presence of
cardiac glycosides.

Phytochemical Screening and Extraction of
Metabolites. Qualitative phytochemical screening
was conducted on the pulverized leaves following
standard methods described by Vinoth et al.,
(2012).

Test for steroids. Dried pulverized plant sample
(0.5 g) was weighed into a clean test tube
containing 2 ml of chloroform. This was then
shaken and filtered. Acetic anhydride and
concentrated hydrogen tetra oxo sulphate (VI) acid
were then added. A positive test was indicated by a
greenish color at the upper part of the liquid.

Test for tannins. Pulverized plant sample (0.5 g)
was stirred with 10ml of distilled water in a test
tube. This was filtered and a few drops of 0.1%
ferric chloride were added. A brownish- green,
blue-black or blue-green precipitate indicates a
positive result.

Test for flavonoids. To query for flavonoids, 0.5
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29213)
were
obtained
from
Molecular
Microbiology Laboratory of the Department of
Pharmaceutical Microbiology, University of
Ibadan. Bacterial strains were isolated from patients
with symptomatic urinary tract infections. The
strains were identified with the Microbact and API
systems by the respective clinical laboratories and
their identities were confirmed using a panel of
biochemical tests including; Gram stain, growth on
appropriate selective media, oxidase test, catalase
test, coagulase test, motility test, DNAse test,
methyl red-voges proskauer test, citrate utilization,
urease test, hydrogen sulfide production,
fermentation of glucose, mannitol, maltose, lactose
and sucrose. (Cheesbrough, 2006) after which they
were archived in agar slants at 40C.

g of plant sample was weighed into a test tube
containing 5 ml of distilled water. This was then
filtered and dilute ammonia was added to the
filtrate. A yellow color, persistent with the addition
of concentrated hydrogen tetra oxo sulphate (VI)
acid indicates a positive result
Test for phenols. Ethyl acetate was used to
extract 1g of plant sample. Extract was then filtered
with Whatman filter paper. The development of
blue black or brown coloration on the addition of
ferric chloride reagent to the filtrate indicates the
presence of phenol.
Test for anthraquinones. Concentrated H2SO4
was added to a clean test tube containing 0.5 g of
plant sample. This was then filtered and chloroform
was added to the filtrate. A color change upon the
addition of ammonium hydroxide indicates a
positive result.
The dried, pulverized leaves of both plants were
extracted successively with the soxhlet apparatus
using n-hexane, ethyl acetate and methanol as
solvents. The plant material was loaded into the
thimble of the soxhlet which was then connected to
a round bottom flask containing the desired solvent.
The flask was mounted on a heating mantle while
the condenser was fixed to the thimble for the
purpose of condensing evaporated solvent. The
condensed solvent drops into the thimble, soaks the
plant sample and thus extracts the components of
the plant. The extracts were then concentrated to
dryness with the aid of a shaker water bath (Lab
Tech shaker, model; LSI-3016R, Korea) set at
60oC. The weight of the extracts was taken after
which they were stored in the refrigerator at -200C.

Antibiotic Susceptibility Testing. Antibiotic
susceptibility testing was conducted on all bacterial
isolates using the disc diffusion technique (CLSI
2016). A panel of standard antibiotic discs which
includes Ceftazidime 30 µg, Cefuroxime 30 µg,
Gentamicin 10 µg, Ofloxacin 5 µg, Augmentin 30
µg, Nitrofurantoin 300 µg, Ciproflxacin 5 µg,
Cloramphenicol 30 µg, Augmentin 30 µg,
Amoxycillin 25 µg, Erythromycin 5 µg,
Tetracycline 10 µg, and Cloxacillin 5 µg were used
for the screening. Isolate suspension equivalent to
0.5 McFarland equivalence turbidity standard for
each isolate was used to inoculate Mueller Hinton
Agar plates with the aid of sterile cotton tipped
applicators. Antibiotic discs were then aseptically
placed on the surface of the agar after which plates
were incubated at 37 0C for 24 hours. Zones of
inhibition were recorded and the results were
interpreted based on CLSI standards and analyzed
with WHONET application.

Microorganisms.
Microbial
strains
of
Escherichia coli (6), Pseudomonas aeruginosa (6),
Klebsiella oxytoca (4), Klebsiella pneumoniae (4),
Proteus vulgaris (3), Proteus mirabilis (3),
Staphylococcus aureus (6) and Staphylococcus
saprophyticus (2) were obtained from the
Department of Medical Microbiology, University
College Hospital, Ibadan, Nigeria and Lancet
Laboratories, Ibadan. Control strains (Escherichia
coli ATCC 35218, Pseudomonas aeruginosa
ATCC 27853, and Staphylococcus aureus ATCC

Antimicrobial
Screening
of
Extracts.
Antimicrobial screening of plant extracts was
conducted using the agar well diffusion method.
Mueller Hinton and Saboraud Dextrose Agar plates
for bacteria and fungi respectively were inoculated
with suspension of each isolate adjusted to 0.5
McFarland Equivalent Turbidity Standard.
Inoculum was evenly spread on the plates with the
aid of sterile cotton tipped applicators. Equidistant
wells were bored on seeded plates with the aid of
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overnight broth culture of each isolate in 5 ml of
TSB was obtained. The isolates used were E. coli
ATCC 35218, S. aureus ATCC 29213 and C.
albicans. Broth cultures of actively growing cells
were diluted and 0.1 ml of the 10-2 dilution was
used to inoculate 3.9 ml TSB containing 1 ml of the
extract at a final concentration equivalent to the
MIC of each isolate. The resultant mixture,
containing extract, culture and broth, was serially
diluted and 100 µl appropriate dilutions were used
to inoculate plates of TSA at different time intervals
beginning at 0 minutes, 1 hour, 1 hour 30 minutes,
2 hours, 3 hours, 4 hours, 5 hours, 6 hours and 24
hours. The inoculum was evenly spread with the aid
of a sterile glass spreader after which the plates
were left for a few minutes to dry. The plates were
then incubated at 37 0C for 24 hours and 250C for
48 hours for bacteria and fungi respectively. The
entire procedure was repeated for extract
concentrations containing 2 times the MIC and 4
times the MIC for each test isolate as well as
controls without extract. After incubation period,
the colony forming unit (CFU) was counted and a
graph of the log of CFU per ml was plotted against
time.

sterile 8 mm diameter cork borer and 0.2 mL of
respective extract dilutions and controls were
aseptically dispensed into corresponding wells and
the plates were incubated at 37 0C for 24 hours for
bacteria and 25 0C for 48 hours for fungi.
Ciprofloxacin and fluconazole were used as the
standard drug control for bacteria and fungi
respectively, while methanol was used as negative
control. Tests were performed in triplicates and
mean diameter of zones of inhibition were recorded
after period of incubation.
Determination
of
Minimum
Inhibitory
Concentration of Extracts. Minimum inhibitory
concentration (MIC) was determined using the agar
dilution method (Klancnik et al., 2010; Wiegand et
al., 2008). Different dilutions of extracts were made
in Mueller Hinton Agar in petri dishes to final
concentrations ranging from 0.39 mg/mL – 50
mg/mL. An overnight broth culture of each isolate
on Tryptone Soy Broth (TSB) was diluted and
inoculated, with the aid of sterile swabs, in agar
plates containing respective extract dilutions. Plates
were incubated at 370C for 24 hours for bacteria and
250C for 48 hours for fungi. The lowest
concentration that prevented growth of isolates was
recorded as the MIC.

Bioactivity Guided Fractionation. Vacuum
liquid chromatography (VLC) was conducted for
the ethyl acetate extract of Ficus thonningii. Fifteen
grams of the crude extract was adsorbed with silica
gel (60-200 mesh size) and VLC was conducted
using 100 mL ratios hexane (Hex), hexane-ethyl
acetate (Hex-EtOAc) mixtures, ethyl acetatemethanol mixtures and methanol as eluents, all in
increasing polarity. A thin layer chromatographic
(TLC) plate was spotted with each fraction and this
was chromatographed with a solvent mixture of
ethyl acetate/methanol (9:1). Similar fractions on
the basis of TLC profiles were pooled.
The pooled fractions from VLC were
concentrated to dryness after which their
antimicrobial activity on selected clinical isolates
was conducted using agar well diffusion method as
described previously.

Determination
of
Minimum
Biocidal
Concentration of Extracts. The Minimum Biocidal
Concentration (MBC) of the bioactive extracts was
determined using concentrations equivalent to the
MIC values, twice, four times and eight times the
MIC values. Overnight broth cultures of isolates
were diluted and 0.5 mL of the 10-2 dilution was
inoculated into 3.5 mL of sterile TSB. Thereafter, 1
mL of each extract dilution which would yield the
desired concentration was dispensed into
appropriately labeled tubes. The tubes were then
incubated at 370C for 24 hours and 250C for 48
hours for bacteria and fungi respectively. Streaking
on fresh Tryptone Soy Agar (TSA) plates was done
from each tube after incubation and the lowest
concentration showing no growth after appropriate
period of incubation was recorded as the MBC.

RESULTS AND DISCUSSION

Time-Kill Assay. Bactericidal Kinetics was
determined using the viable count technique. An

The phytochemicals present in F. thonningi
313

Coker and Oaikhena: Antimicrobial Activity of the crude extracts and fractions of <em

Flavonoids for instance are very effective against a
wide range of organisms (Tsuchiya et al., 1996) and
they probably do this by forming complexes with
bacterial cell walls as well as extracellular and
soluble proteins. Terpenoids are bactericidal as they
distort the structure and integrity of the microbial cell
membrane, leading to cell lysis (Cowan, 1999).
These and other phytochemicals present in the plant
might have resulted in the medicinal property of the
plant. Indeed, it has been proposed and elucidated
that different phytochemicals act synergistically to
produce the overall antimicrobial effect associated
with medicinal plants (Padmanabhan and Jangle,
2012).
Clinical isolates showed a high rate of resistance
to standard antibiotics. The majority of strains were
Multi Drug-Resistant (MDR), Possible Extensively
Drug-Resistant (PXDR) or Possible Pan DrugResistant (PPDR) (CLSI, 2016; Magiorakos et al.,
2011). There was a high rate of resistance among the
Pseudomonas aeruginosa isolates as all were
classified as PXDR. All these correlated with the
studies of (Neuhauser et al., 2003; Okon et al., 2014)
which reported increasing resistance amongst P.
aeruginosa and other Gram negative bacilli. The
resistance profile of Proteus vulgaris was
remarkable as the isolates were resistant to almost all
the antibiotics employed. Only one isolate was
sensitive to nitrofurantoin. It is important to state that
the resistance recorded in this study cannot be
extrapolated to the general population of organisms
in the communities or areas where the isolates were
collected as the number of each species of organisms
used in this study is small, with the aim of merely
testing the activity of the extracts on them. However,
antibiotic susceptibility testing was necessary to
know the susceptibility pattern of the isolates.
The zones of inhibition shown by the hexane
extract were small and as such it could be said that it
had just minimal activity on test isolates or that the
antimicrobial principles did not diffuse well.
However the activity was consistent with
concentration of the extract. The ethyl acetate extract
was active against the isolates, producing
appreciable zones of inhibition on both bacteria and
fungi. Also, the ethyl acetate extract exhibited better

include terpenoids, anthraquinones, saponins,
tannins and alkaloids. Cardiac glycosides and
steroids were absent (Figures 1 and 2) Clinical
isolates used in this study were mostly multi-drug
resistant. All Gram negative clinical bacteria used in
this study were resistant to ampicillin and augmentin
while Staphylococci were resistant to ceftazidime.
The ethyl acetate extracts of F. thonningii produced
larger zones of inhibition on clinical isolates than
hexane and methanolic extracts as in Table 1. MIC
and MBC values of ethyl acetate extract, as recorded
in Table 2 are in the range of 6.25 mg/mL and ≥50
mg/mL. Pooled fractions of ethyl acetate extracts
produced appreciable zones of inhibition, greater
than the crude extract (Table 3). The ethyl acetate
extract inhibited the growth of E. coli ATCC 35218,
S. aureus ATCC 29213 and C. albicans by 100% at
1440 minutes, 390 minutes and 210 minutes
respectively (Figures 3 – 5).
Some of the phytochemicals present in F.
thonningii, as captured above have been reported
previously. Egharevba et al., (2015) reported the
presence of saponins, tannins and flavonoids as well
as absence of cardiac glycosides and steroids on F.
thonningii. However, anthraquinones and alkaloids
which were found in this work were absent in their
study. Similarly, alkaloids and flavonoids as well as
cardiac glycosides (which was absent in this study)
were detected in F. thonningii (Oyelana et al., 2011).
Also, the main groups of phytochemicals present in
F. thonningii as reported by (Dangarembizi et al.,
2013) are alkaloids, terpenoids, flavonoids, tannins
and essential oils. Worthy of note is the presence of
anthraquinones observed in this study for F.
thonningii as this was not reported in any literature
encountered in the course of this work. The
differences in phytochemicals detected in these
studies could be as a result of difference in locations
where the plants were collected as it has been shown
that plant site affects it antimicrobial activity (Knief
et al., 2010; Laforest-Lapointe et al., 2016). An array
of phytochemicals isolated and identified from plants
has been shown to confer varying degrees of
antimicrobial properties to plants. It is believed that
most plants produce such secondary metabolites in
response to stress and invasion by microbes.
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fractions produced zones of inhibition indicating that
there could be several compounds conferring
antimicrobial activity to the plant. Zones produced
by fractions were also larger than the crude,
suggesting that further purification and isolation of
active compounds would reduce the MICs and
MBCs.
The extract at 4MIC produced 100% inhibition of
E. coli strain at 24 hours. At the 2MIC and 1MIC,
growth was moderately reduced but at the time 24
hours, there were still counts on plates. On S. aureus,
the 4MIC and 2MIC resulted in 100% inhibition at 6
hours 30 minutes and 24 hours respectively. As
observed with E. coli, growth was reduced at 1MIC
but death was not recorded at 24 hours. In essence
the extract was more effective in killing the Gram
positive
organism
(Staphylococcus
aureus)
employed in this study than the Gram negative
(Escherichia coli) as shown by the time-kill curves.
The extract at 4MIC and 2MIC led to death of C.
albicans. However, at 1 MIC growth reduced a bit up
until after four hours before increasing until the end
of the experiment, suggesting that that concentration
is not sufficient to kill the fungus. The presence of
growth at concentrations where only reductions but
not kill was observed after the duration of the study
does not definitely mean that death would not be
achieved at such concentrations, especially as
reduction was evident. Instead, it could indicate that
had the experiment be conducted for longer duration,
death would possibly have been observed.
This study has shown that F. thonningii is active
on pathogens isolated from human urinary tract, thus
corroborating its possible application in the
treatment of urinogenital tract infections, treating
even drug resistant infections if developed into
standard drugs with further research.

activity than hexane and methanol extracts, showing
larger zones of inhibition. The methanol extract of F.
thonningii was only moderately active against
susceptible isolates showing lower zones of
inhibition than the ethyl acetate extract but larger
zones than the hexane. F. thonningii has been shown
to be active against several bacterial pathogens
(Usman et al., 2009; Koné et al., 2004; Ndukwe et
al., 2007), similar to the observation in this study.
The standard drug control (ciprofloxacin 10
µg/mL) was active against only a few isolates.
Although the activity of plant extracts, containing a
lot of unknown and unstandardized substances,
cannot be compared with standard drugs, the ethyl
acetate extracts proved quite active. It produced
appreciable zones of inhibition even on isolates that
were resistant to the standard drug control and other
drugs, including MDR, PXDR and PPDR bacteria.
The activity of the plant extract on PPDR bacteria
was observed keenly as this could be potentially
useful in treating multi-drug resistant infections
which continues to be a public health problem. This
suggests that F thonningii may be possible leads in
the development of potential antimicrobial agents
against UTI infections.
Minimum Inhibitory Concentrations of the
extracts were quite high and this may be partly due
to the fact that the extracts are crude, containing an
array of unknown substances which made up the
weight for concentrations, most of which may be
inactive. Similarly, as expected based on the MIC
values, the Minimum Biocidal Concentrations were
high ranging from 6.25 mg/mL to above 50 mg/mL.
MIC and MBC values for some isolates were the
same; this suggests that the extract exerts its
antimicrobial activity by killing rather than
preventing the growth of susceptible bacteria.
VLC fractionation was conducted for the most
active extract which was that of ethyl acetate.
Antimicrobial screening of VLC fractions against
representative isolates was conducted after pooling
of fractions based on TLC profiles. The results of
antimicrobial screening against test isolates showed
the most active fraction to be fraction 1. This
indicates that the active compounds of the plant are
probably non-polar in nature. Nevertheless, all
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Figure 1: Percentage resistance of Gram negative isolates
to select antibiotics. ‘Pae’ = Pseudomonas aeruginosa;
‘Eco’ = Escherichia coli; ‘Kpn’ = Klebsiella
pneumoniae; ‘Kox’ = Klebsiella oxytoca; ‘Pmi’ =
Proteus mirabilis; ‘Pvu’ = Proteus vulgaris

Figure 3: Kill Kinetics of the Ethyl Acetate Extract of F.
thonningii on Escherichia coli ATCC 35218

Figure 2: Percentage resistance of Gram positive isolates
to select antibiotics. ‘Sau’ = Staphylococcus aureus;
‘Ssa’ = Staphylococcus saprophyticus

Figure 4: Kill Kinetics of the Ethyl Acetate Extract of F.
thonningii on Staphylococcus aureus ATCC 29213
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Figure 5: Kill Kinetics of the Ethyl Acetate Extract of
F. thonningii on Candida albicans 4
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Table 1: Antimicrobial Screening of Crude Extracts on Clinical Isolates
Concentration
Isolate
P. aeruginosa 1
P. aeruginosa 2
P. aeruginosa 3
P. aeruginosa 4
P. aeruginosa 5
E. coli 1
E. coli 2
E. coli 3
E. coli 4
E. coli 5
K. pneumoniae 1
K. pneumoniae 2
K. pneumoniae 3
K. pneumoniae 4
K. oxytoca 1
K. oxytoca 2
K. oxytoca 3
K. oxytoca 4
P. mirabilis 1
P. mirabilis 2
P. mirabilis 3
P. vulgaris 1
P. vulgaris 2
P. vulgaris 3
S. aureus 1
S. aureus 2
S. aureus 3
S. aureus 4
S. aureus 5
S. saprophyticus 1
S. saprophyticus 2
C. albicans 1
C. albicans 2
C. albicans 3
C. albicans 4

100
mg/mL
NZI
9.3 ± 0.5
12.3 ± 0.5
10.7 ± 0.5
13.3 ± 0.5
NZI
NZI
NZI
NZI
10.3 ± 1.2
NZI
11.3 ± 0.5
10.3 ± 1.2
11.0 ± 0.8
NZI
NZI
12.3 ± 1.2
NZI
14.3 ± 0.5
NZI
10.0 ± 0.8
12.0 ± 0.8
10.3 ± 0.5
12.0 ± 0.0
14.3 ± 0.5
11.7 ± 1.2
NZI
15.7 ± 0.9
14.3 ± 2.1
10.3 ± 0.5
13.7 ± 0.9
10.3 ± 0.5
10.7 ± 0.5
11.3 ± 0.5
10.0 ± 0.8

Hexane extract
50
25
mg/mL
mg/mL
NZI
NZI
10.0 ± 0.0
10.5 ± 0.5
12.3 ± 1.2
NZI
NZI
NZI
NZI
NZI
NZI
NZI
11.3 ± 1.2
9.0 ± 0.0
NZI
NZI
10.3 ± 0.5
NZI
15.3 ± 0.5
NZI
NZI
14.7 ± 1.2
10.0 ± 0.0
10.7 ± 1.7
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
10.0 ± 0.0
10.3 ± 0.5
9.0 ± 0.0

NZI
NZI
NZI
10.7 ± 0.5
10.3 ± 0.5
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
13.7 ± 0.5
NZI
NZI
11.7 ± 1.2
NZI
NZI
NZI
NZI
NZI
NZI
10.0 ± 1.0
NZI
NZI
NZI
9.0 ± 0.0
10.0 ± 0.0
NZI

Ethyl acetate extract
Methanol extract
100
50
25
100
50
25
mg/mL
mg/mL
mg/mL
mg/mL
mg/mL
mg/mL
Zones of Inhibition (mm)
11.0 ± 0.8 14.0 ± 1.4 11.7 ± 0.5 12.3 ± 0.5 12.0 ± 0.0 11.3 ± 0.5
14.0 ± 0.8 12.7 ± 0.5 12.3 ± 0.5 16.3 ± 0.5 15.3 ± 0.5 12.0 ± 0.0
18.3 ± 1.2 13.3 ± 0.5 11.0 ± 0.0 14.3 ± 0.5 13.0 ± 0.0 12.3 ± 1.2
17.3 ± 0.5 14.3 ± 0.5 13.3 ± 0.5 14.7 ± 0.5 14.0 ± 0.8 12.0 ± 0.0
18.0 ± 0.8 15.0 ± 0.0 13.7 ± 1.2 14.0 ± 0.0 12.0 ± 0.8 10.7 ± 0.5
13.0 ± 0.0 10.3 ± 0.5
9.3 ± 0.5
NZI
NZI
NZI
17.3 ± 0.9 12.3 ± 1.2 10.7 ± 0.5 12.3 ± 0.5 11.0 ± 0.8 10.3 ± 0.5
13.3 ± 0.5 11.0 ± 0.0
NZI
13.0 ± 0.8
NZI
NZI
14.7 ± 0.9 12.3 ± 0.5 11.3 ± 0.5 12.0 ± 0.0 10.3 ± 0.5 10.0 ± 0.0
14.3 ± 0.5 11.3 ± 0.5 10.7 ± 0.5 10.7 ± 0.5
9.7 ± 0.5
11.3 ± 1.2
12.0 ± 0.8
9.0 ± 0.8
NZI
NZI
NZI
NZI
19.3 ± 1.2 12.3 ± 0.5 10.7 ± 0.5 12.3 ± 0.5 10.0 ± 0.0
9.5 ± 0.5
12.3 ± 0.5 10.3 ± 0.5
NZI
NZI
NZI
NZI
14.7 ± 0.9
NZI
NZI
NZI
NZI
NZI
16.0 ± 0.8 14.0 ± 0.0 12.3 ± 0.5
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
13.3 ± 0.5 10.3 ± 0.9
NZI
17.5 ± 0.5 12.7 ± 0.5 12.0 ± 0.0
NZI
NZI
NZI
17.0 ± 0.8
NZI
NZI
19.7 ± 0.9 18.3 ± 0.5 14.0 ± 0.0
NZI
NZI
NZI
16.0 ± 0.8 14.7 ± 0.5 12.3 ± 2.1
NZI
NZI
NZI
15.7 ± 0.9 12.3 ± 0.5 11.7 ± 0.5 12.0 ± 0.0 10.7 ± 0.5
NZI
22.0 ± 1.4 13.0 ± 0.8 11.0 ± 0.0 14.7 ± 0.9 12.3 ± 0.5 10.0 ± 0.0
20.7 ± 1.7 13.3 ± 0.5 12.0 ± 0.0 19.3 ± 0.5 10.3 ± 0.5
NZI
15.3 ± 0.5 12.0 ± 0.0 11.0 ± 0.8 11.0 ± 0.8 10.3 ± 0.5
9.0 ± 0.0
17.0 ± 1.4 13.0 ± 0.8 12.7 ± 0.5 12.3 ± 0.5 12.0 ± 0.0
9.3 ± 0.5
22.0 ± 0.8 15.3 ± 1.2 12.7 ± 0.5 12.3 ± 0.5 10.3 ± 0.5 10.0 ± 0.0
12.7 ± 1.2 14.3 ± 0.5 13.3 ± 0.5 14.0 ± 0.8 12.0 ± 0.0 10.7 ± 0.5
17.3 ± 0.5 16.7 ± 0.5 12.0 ± 0.0 14.7 ± 1.2 11.7 ± 0.9
9.0 ± 0.0
20.0 ± 0.0 15.0 ± 0.8 12.3 ± 0.5 12.0 ± 0.0 10.3 ± 0.5
NZI
25.3 ± 0.5 18.3 ± 0.5 15.3 ± 0.5 14.3 ± 0.5 11.0 ± 0.0
NZI
19.3 ± 0.5 15.0 ± 0.0 13.7 ± 0.5 12.0 ± 0.0 11.0 ± 0.0 10.7 ± 0.5
15.0 ± 0.8 13.3 ± 0.5 10.0 ± 0.0 13.3 ± 0.5 9.3 ± 0.5
9.5 ± 0.5
15.7 ± 1.7 13.0 ± 0.0 11.3 ± 0.5 10.7 ± 0.5 9.3 ± 0.5
9.7 ± 0.5
16.3 ± 0.5 13.0 ± 0.8 12.7 ± 0.9 12.0 ± 0.0 11.7 ± 0.5 10.0 ± 0.8
16.0 ± 0.8 13.7 ± 0.9 12.3 ± 0.5 10.0 ± 0.0 9.7 ± 0.5
9.0 ± 0.0

Ciprofloxacin
10
µg/mL

Fluconazole
50
µg/mL

NZI
27.7.± 1.3
NZI
23.7 ± 1.3
30.3 ± 1.3
27.7 ± 0.9
28.7 ± 1.3
27.3 ± 0.5
NZI
NZI
NZI
NZI
NZI
NZI
NZI
NZI
20.7 ± 2.5
NZI
NZI
20.7 ± 0.9
NZI
NZI
NZI
NZI
NZI
21.0 ± 0.8
29.0 ± 0.8
NZI
NZI
NZI
NZI
NT
NT
NT
NT

NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NT
NZI
NZI
NZI
14.7 ± 0.9

Key: ‘E. coli’ = Escherichia coli; ‘P. aeruginosa’ = Pseudomonas aeruginosa; ‘K. pneumoniae’ = Klebsiella pneumonia; ‘K. oxytoca’ = Klebsiella oxytoca; ‘P. mirabilis’ = Proteus
mirabilis; ‘P. vulgaris’ = Proteus vulgaris; ‘S. aureus’ = Staphylococcus aureus; ‘S. saprophyticus’ = Staphylococcus saprophyticus;‘NZI’ = no zone of inhibition ‘NT’ = not tested
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Table 2: Minimum Inhibitory Concentration (MIC) and Minimum Biocidal Concentrations of the Ethyl Acetate Extracts
Isolates
Isolate
MIC (mg/mL)
MBC (mg/mL)
P. aeruginosa ATCC 27853
12.5
12.5
P. aeruginosa 1
6.25
12.5
P. aeruginosa 2
12.5
25.0
P. aeruginosa 3
12.5
12.5
P. aeruginosa 4
12.5
25.0
P. aeruginosa 5
12.5
25.0
E. coli ATCC 35218
12.5
12.5
E. coli 1
6.25
50.0
E. coli 2
6.25
25.0
E. coli 3
12.5
50.0
E. coli 4
12.5
25.0
E. coli 5
6.25
25.0
K. pneumoniae 1
6.25
50.0
K. pneumoniae 2
12.5
25.0
K. pneumoniae 3
12.5
50.0
K. pneumoniae 4
12.5
50.0
K. oxytoca 1
12.5
25.0
K. oxytoca 2
12.5
≥50
K. oxytoca 3
12.5
25.0
K. oxytoca 4
12.5
≥50
P. mirabilis 1
12.5
12.5
P. mirabilis 2
12.5
12.5
P. mirabilis 3
6.25
12.5
P. vulgaris 1
12.5
25.0
P. vulgaris 2
12.5
25.0
P. vulgaris 3
12.5
12.5
S. aureus ATCC 29213
12.5
12.5
S. aureus 1
12.5
12.5
S. aureus 2
12.5
12.5
S. aureus 3
12.5
12.5
S. aureus 4
12.5
12.5
S. aureus 5
12.5
25.0
S. saprophyticus 1
6.25
12.5
S. saprophyticus 2
12.5
12.5
Key: ‘E. coli’ = Escherichia coli
‘P. aeruginosa’ = Pseudomonas aeruginosa
‘K. pneumoniae’ = Klebsiella pneumoniae ‘K. oxytoca’ = Klebsiella oxytoca
‘P. mirabilis’ = Proteus mirabilis
‘P. vulgaris’ = Proteus vulgaris
‘S. aureus’ = Staphylococcus aureus
‘S. saprophyticus’ = Staphylococcus saprophyticus
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Table 3: Antimicrobial Screening of VLC pooled fractions of F. thonningii
Concentration

Fraction 1
50
25
mg/mL
mg/mL

Isolate

Fraction 2
50
25
mg/mL
mg/mL
Zones of Inhibition (mm)

Fraction 3
50
25
mg/mL
mg/mL

P. aeruginosa 2

31

15

18

14

14

11

E. coli 2

21

15

12

11

10

NZI

K. pneumoniae 1

24

10

13

10

10

9

K. oxytoca 2

23

14

14

11

10

NZI

S. aureus 2

30

22

15

14

12

NZI

S. saprophyticus 2

29

27

18

12

15
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